(Q51800488)

English

A feasibility study of sequential paclitaxel and S-1 (PTX/S-1) chemotherapy as postoperative adjuvant chemotherapy for advanced gastric cancer.

scientific article published in January 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/16767367

A feasibility study of sequential paclitaxel and S-1 (PTX/S-1) chemotherapy as postoperative adjuvant chemotherapy for advanced gastric cancer. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/16767367

1 reference

based on heuristic

inferred from title

author name string

Michiya Kobayashi

1

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/16767367

Akira Tsuburaya

2

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/16767367

Naoki Nagata

3

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/16767367

Yumi Miyashita

4

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/16767367

Koji Oba

5

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/16767367

Junichi Sakamoto

6

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/16767367

publication date

1 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/16767367

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/16767367

9

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/16767367

2

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/16767367

114-119

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/16767367

https://scigraph.springernature.com/pub.10.1007/s10120-006-0364-9

0 references

Pharmacokinetic study of paclitaxel in malignant ascites from advanced gastric cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS10120-006-0364-9

21 January 2018

Unusual survival for more than 2 years with peritoneal metastases of gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16767367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16767367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16767367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pilot study of S-1 in patients with disseminated gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16767367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of microscopic peritoneal dissemination: comparison between colon and gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16767367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized phase III trial of post-operative adjuvant oral fluoropyrimidine versus sequential paclitaxel/oral fluoropyrimidine; and UFT versus S1 for T3/T4 gastric carcinoma: the Stomach Cancer Adjuvant Multi-institutional Trial Group (Samit) Tria

1 reference

https://pubmed.ncbi.nlm.nih.gov/16767367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination

1 reference

https://pubmed.ncbi.nlm.nih.gov/16767367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastric cancer treatment guidelines in Japan

1 reference

https://pubmed.ncbi.nlm.nih.gov/16767367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16767367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/16767367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Post-operative chemotherapy in non-curative gastrectomy for advanced gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16767367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An early phase II study of oral S-1, a newly developed 5-fluorouracil derivative for advanced and recurrent gastrointestinal cancers. The S-1 Gastrointestinal Cancer Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/16767367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral fluoropyrimidine anticancer drug TS-1 for gastric cancer patients with peritoneal dissemination.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16767367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors influencing outcome in gastric cancer involving muscularis and subserosal layer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16767367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16767367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Different patterns of recurrence in gastric cancer depending on Lauren's histological type: longitudinal study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16767367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effective weekly paclitaxel administration for gastric cancer with malignant ascites--a case report

1 reference

https://pubmed.ncbi.nlm.nih.gov/16767367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[A case of metastatic gastric cancer responding to weekly administration of paclitaxel as a second-line therapy]

1 reference

https://pubmed.ncbi.nlm.nih.gov/16767367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Retrospective analysis of clinical results and predictors of response in chemo-naive patients with advanced gastric cancer treated with S-1, an oral fluoropyrimidine derivative, as single-agent chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16767367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10120-006-0364-9

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/16767367

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/16767367

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51800488&oldid=1561392945"